Imperva Inc (NASDAQ:IMPV) Director Anthony J. Bettencourt sold 66,037 shares of Imperva stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $46.98, for a total value of $3,102,418.26. Following the sale, the director now directly owns 66,037 shares in the company, valued at $3,102,418.26. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Imperva Inc (NASDAQ IMPV) traded down $0.40 during trading hours on Friday, reaching $47.10. The company had a trading volume of 260,400 shares, compared to its average volume of 384,104. The firm has a market capitalization of $1,615.66, a P/E ratio of 69.26 and a beta of 1.79. Imperva Inc has a fifty-two week low of $37.17 and a fifty-two week high of $52.40.
Imperva (NASDAQ:IMPV) last issued its earnings results on Thursday, February 8th. The software maker reported $0.40 EPS for the quarter, beating the Zacks’ consensus estimate of $0.27 by $0.13. Imperva had a negative return on equity of 3.37% and a net margin of 7.11%. The company had revenue of $91.10 million during the quarter, compared to the consensus estimate of $91.11 million. During the same period in the previous year, the firm posted $0.32 earnings per share. Imperva’s quarterly revenue was up 16.2% compared to the same quarter last year. analysts predict that Imperva Inc will post -0.17 earnings per share for the current year.
IMPV has been the topic of a number of analyst reports. Evercore ISI reaffirmed a “buy” rating and set a $56.00 target price on shares of Imperva in a research report on Wednesday, November 8th. Stifel Nicolaus reaffirmed a “hold” rating and set a $47.00 target price (down from $50.00) on shares of Imperva in a research report on Thursday, November 9th. Oppenheimer reaffirmed a “buy” rating and set a $55.00 target price on shares of Imperva in a research report on Thursday, November 9th. Morgan Stanley reaffirmed an “underweight” rating and set a $39.00 target price on shares of Imperva in a research report on Thursday, November 9th. Finally, JPMorgan Chase & Co. downgraded Imperva from a “neutral” rating to an “underweight” rating and set a $45.00 price target for the company. in a research note on Tuesday, December 12th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $53.14.
ILLEGAL ACTIVITY NOTICE: “Anthony J. Bettencourt Sells 66,037 Shares of Imperva Inc (IMPV) Stock” was published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright laws. The original version of this piece of content can be viewed at https://www.com-unik.info/2018/02/23/anthony-j-bettencourt-sells-66037-shares-of-imperva-inc-impv-stock.html.
Imperva Company Profile
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.